Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Patient-centred care

Patient-centred interventions for multimorbidity do not improve quality of life, study shows

Interventions to improve the care of people with multiple chronic conditions do not have a significant impact on quality of life or clinical outcomes, but do improve patient experience of care, study suggests.

Patient-centred interventions


Research published in The Lancet shows that patient-centred interventions to improve care of people with multiple chronic conditions do not improve quality of life or clinical outcomes

Patient-centred interventions to improve care of people with multiple chronic conditions do not improve quality of life or clinical outcomes, according to the findings of a UK study published in The Lancet[1].

The research involved adults with at least 3 of 17 major chronic conditions under the care of 33 GP practices in England and Wales who were randomly assigned to the intervention or to continue receiving usual care.

Patients assigned to the intervention were invited to a comprehensive, holistic (as opposed to disease-specific) review at their GP surgery with both a nurse and their doctor, followed by a records-based medication review by a pharmacist every six months. Overall, 797 patients were recruited to the intervention and 749 patients to usual care. Outcomes were assessed after 15 months.

Overall, there was no significant difference between the two groups with regard to quality of life (measured by EQ-5D-5L score) or in any measure of illness and treatment burden, such as self-rated health, Hospital Anxiety and Depression score or Morisky Medication Adherence score.

However, patients in the intervention group did report a significant improvement in patient-centred care outcomes, such as having a written treatment plan, being able to discuss the problem most important to them, and satisfaction with their care.

The researchers, led by Chris Salisbury at the National Institute for Health Research School for Primary Care Research, Bristol Medical School, explained that there was an international consensus that care for multimorbidity should be patient-centred and should focus on self-management and quality of life.

However, the evidence base to support this is inadequate, as highlighted by a 2016 Cochrane review of the existing research. The authors of the current study said it was the largest trial to date of an intervention to improve the management of multimorbidity.

Salisbury and colleagues concluded that the evidence base indicated limited or no impact of interventions for multimorbidity on quality of life. However, they acknowledged that improving patient experience of care was an important goal in itself.

“Providing care that is demonstrably more patient-centred is arguably sufficient justification for implementation in itself, especially since our evidence shows it is not associated with disadvantages in terms of disease management or hospital use,” they concluded.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205095

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Clinical Pharmacokinetics

    Clinical Pharmacokinetics

    A practical guide to the use of pharmacokinetic principles in clinical practice. Includes case studies with questions and answers.

    £33.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • MCQs in Clinical Pharmacy

    MCQs in Clinical Pharmacy

    Four practice tests, each with 80 practice-oriented MCQs. Assess your knowledge of clinical issues, evaluative and analytical skills.

    £25.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Doctor discussing intervention with a patient

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.